Oncology

A Beacon of Hope: Personalized mRNA Vaccine Targets Pancreatic Cancer Recurrence

A Beacon of Hope: Personalized mRNA Cancer Vaccine Shows Promise Against Pancreatic Cancer

A New Frontier in Cancer Treatment: The Promise of mRNA Vaccines

A Glimmer of Hope: New Experimental Treatment Offers Breakthrough for Pancreatic Cancer Patients

ALX Oncology Strengthens Leadership, Welcomes Biotech Veteran Jeff Knight as Chief Development and Operating Officer

A New Era of Hope: Revolutionizing Pancreatic Cancer Treatment

Telix and Regeneron Unite: A Groundbreaking Alliance for Radiopharmaceutical Innovation

BioNTech Navigates Shifting Tides: Q1 2026 Showcases Pipeline Progress Amidst Revenue Recalibration

Avacta Marks Pivotal Moment: First Patient Dosed in AVA6103 Cancer Trial

A New Chapter Unfolds: Cue Biopharma Announces Leadership Transition Amidst Clinical Advancements

Lantern Pharma Gears Up to Unveil Its Transformative 2025 Financial Story and Operational Triumphs

A New Dawn in Prostate Cancer Treatment: Turbocharging the Immune System

Molecular Partners Charts a Course for Innovation: Major Cancer Research Unveiling at AACR 2026

Unlocking New Hope: BlossomHill Therapeutics Takes Aim at Toughest KRAS Cancers

A Glimmer of Hope: Beyond Cancer's Early Clinical Results Spark Optimism

A New Dawn for Breast Cancer Survivors: Quebec Pioneers Personalized Follow-Up

A Stinging Setback: Incyte's Cancer Therapy Fails to Clear FDA's High Bar

Aurora Investments Makes Bold Bet on Groundbreaking Healthcare Stock, Sets Ambitious $260 Price Target

AstraZeneca's Stellar Q4 Performance: Cancer Drugs Propel Growth and Investor Confidence

A Silent Killer No More? New Blood Test Offers Hope for Early Pancreatic Cancer Detection

Unlocking the Body's Internal Clock: How Timing Could Transform Cancer Treatment

The Lingering Shadow: How Pandemic Disruptions Quietly Worsened the Fight Against Cancer

A Surprising Turn: Autoimmune Side Effects Linked to Better Outcomes in Immunotherapy

Amgen's Horizon: Bradway Shares Strategic Vision with Cramer

More Than Business: Incyte's Identity Forged in the Blood Cancer Battle

Unlocking New Frontiers: How Revolution Medicines and Merck Are Redefining the Cancer Fight

A New Dawn in Cancer Diagnosis: The AI Revolution

A Glimmer of Hope: Syndax's Novel AML Drug Shines Bright at ASH Meeting

A New Dawn in Cancer Detection: Freenome's Bold Move Towards Public Markets

A New Chapter for NCCN: Dr. Renuka Iyer Appointed Chief Medical Officer

The Pharmaceutical Pulse: A Year-End Reflection on Innovation, Politics, and Public Trust in 2025

The Anticipation Builds: ASH 2025 and the Evolving Landscape of Blood Cancer Therapies

Pharma's Unfolding Drama: 340B Clashes, Vaccine Progress, and Cancer Innovation

A New Dawn for Skin Cancer Patients: Citius Oncology Launches Lymphir in the US

AI Drug Discovery Takes a Giant Leap: Iambic Therapeutics Secures $100M

A Whiff of Hope: Could a Simple Nasal Spray Be Our Next Weapon Against Brain Cancer?

The Silent Toll: How Delayed Cancer Diagnoses Steal Futures, and the Beacon of Personalized Treatment

Urogen Pharma: Unpacking the Quiet Potential of ZUSDURI in Bladder Cancer

A Radical New Way to Fight Cancer: Precision Particles, Unprecedented Hope